Clinical Trial Update: Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating lithium, cord blood cells, and their combination for spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Cord Blood Cells (cord blood cell therapy)
• Lithium (Lithium carbonate)

Snippet

Sponsor: China Spinal Cord Injury Network | Conditions: Spinal Cord Injury | Phase 1, Phase 2 | Status: COMPLETED